SCHEMBL9923902

SCHEMBL9923902

COC(=O)c1ccc(S(=O)(=O)Nc2nc3ccccn3c2C(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 2/20 0.46
FBP1 P09467 1/20 0.45
MAPT P10636 2/20 0.45
PLAU P00749 2/20 0.45
DAPK3 O43293 1/20 0.43
JAK2 O60674 1/20 0.43
PRKD3 O94806 1/20 0.43
MAP4K4 O95819 1/20 0.43
ABL1 P00519 1/20 0.43
CSF1R P07333 1/20 0.43
RET P07949 1/20 0.43
MET P08581 1/20 0.43
PDGFRA P16234 1/20 0.43
PRKACA P17612 1/20 0.43
LTK P29376 1/20 0.43
GRK5 P34947 1/20 0.43
KDR P35968 1/20 0.43
MAPK8 P45983 1/20 0.43
MAPK9 P45984 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9893368 0.99 ALDH1A1 (0.45) ALDH1A1KDM4EFBP1MAPTPLAU
SCHEMBL9893198 0.86 ALDH1A1 (0.48) ALDH1A1KDM4EFBP1MAPTPLAU
SCHEMBL9893277 0.76 ALDH1A1 (0.66) ALDH1A1KDM4EMAPTDAPK3JAK2
SCHEMBL9923898 0.75 ALDH1A1 (0.40) ALDH1A1KDM4EFBP1MAPTPLAU
SCHEMBL9893330 0.72 MAPT (0.47) ALDH1A1KDM4EFBP1MAPTPLAU
SCHEMBL9893404 0.71 ALDH1A1 (0.46) ALDH1A1KDM4EKMT2ASMN1; SMN2GAA
SCHEMBL9893199 0.71 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTPLAUMEN1
SCHEMBL9924043 0.71 KMT2A (0.48) ALDH1A1KDM4EMAPTPLAUKDR
SCHEMBL9905580 0.70 TRPM8 (0.56)
Hydrochloric Acid SCHEMBL9893200 0.70 KMT2A (0.47) ALDH1A1KDM4EMAPTPLAUKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9067935-B2 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2015-06-30 US disclosed
US-9067935-B2 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2015-06-30 US disclosed
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2014-03-27 US disclosed
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2014-03-27 US disclosed
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2012-06-14 US disclosed
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 ALDH1A1 2230/4885KDM4E 3480/4885FBP1 1589/4885
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 ALDH1A1 2230/4885KDM4E 3480/4885FBP1 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.